JP2005533036A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533036A5
JP2005533036A5 JP2004508891A JP2004508891A JP2005533036A5 JP 2005533036 A5 JP2005533036 A5 JP 2005533036A5 JP 2004508891 A JP2004508891 A JP 2004508891A JP 2004508891 A JP2004508891 A JP 2004508891A JP 2005533036 A5 JP2005533036 A5 JP 2005533036A5
Authority
JP
Japan
Prior art keywords
ester
long
solution according
acting
progestogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004508891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533036A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/050192 external-priority patent/WO2003101539A1/en
Publication of JP2005533036A publication Critical patent/JP2005533036A/ja
Publication of JP2005533036A5 publication Critical patent/JP2005533036A5/ja
Pending legal-status Critical Current

Links

JP2004508891A 2002-05-30 2003-05-23 油性溶液の自己投与型避妊注射 Pending JP2005533036A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077126 2002-05-30
PCT/EP2003/050192 WO2003101539A1 (en) 2002-05-30 2003-05-23 Self-administered contraceptive injection of oily solution

Publications (2)

Publication Number Publication Date
JP2005533036A JP2005533036A (ja) 2005-11-04
JP2005533036A5 true JP2005533036A5 (enExample) 2006-07-06

Family

ID=29595016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004508891A Pending JP2005533036A (ja) 2002-05-30 2003-05-23 油性溶液の自己投与型避妊注射

Country Status (23)

Country Link
US (1) US20060094698A1 (enExample)
EP (1) EP1513587A1 (enExample)
JP (1) JP2005533036A (enExample)
KR (1) KR20050010014A (enExample)
CN (1) CN1298330C (enExample)
AR (1) AR040131A1 (enExample)
AU (1) AU2003238084A1 (enExample)
BR (1) BR0311423A (enExample)
CA (1) CA2487639A1 (enExample)
HR (1) HRP20041126A2 (enExample)
IL (1) IL165204A0 (enExample)
IS (1) IS7539A (enExample)
MX (1) MXPA04011928A (enExample)
NO (1) NO20044976L (enExample)
NZ (1) NZ536735A (enExample)
PE (1) PE20040676A1 (enExample)
PL (1) PL373074A1 (enExample)
RS (1) RS100904A (enExample)
RU (1) RU2328289C2 (enExample)
TW (1) TW200404552A (enExample)
UA (1) UA80822C2 (enExample)
WO (1) WO2003101539A1 (enExample)
ZA (1) ZA200409646B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
KR20150011346A (ko) 2012-04-06 2015-01-30 안타레스 팔마, 인코퍼레이티드 테스토스테론 조성물의 바늘-보조식 젯 주입 투여 장치 및 방법
WO2014093818A2 (en) * 2012-12-14 2014-06-19 Bioject, Inc. Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
DK2953667T3 (da) * 2013-02-11 2020-01-27 Antares Pharma Inc Nålestøttet jetinjektionsindretning med reduceret udløserkraft
WO2015023557A1 (en) 2013-08-12 2015-02-19 Nanomedical Systems, Inc. Device and method for sustained release of low water solubility therapeutic agent in solubilizer
CN114026106B (zh) * 2019-03-06 2025-01-21 普洛拉治疗公司 阿比特龙前药
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2970153A (en) * 1959-07-27 1961-01-31 Leo Ab Alkoxyphenyl-propionyl esters of 17alpha-hydroxyprogesterone
DE3836862A1 (de) * 1988-10-27 1990-05-03 Schering Ag Mittel zur transdermalen applikation von steroidhormonen
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
CN1135716A (zh) * 1993-12-27 1996-11-13 阿克佐诺贝尔公司 经皮吸收的药用制剂
US5599302A (en) * 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
WO1997003709A1 (de) * 1995-07-17 1997-02-06 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
TR200003743T2 (tr) * 1998-06-19 2001-07-23 Akzo Nobel N.V. Testosteron türevi.
WO1999067270A1 (en) * 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
RU2002124602A (ru) * 2000-02-15 2004-03-10 Шеринг Акциенгезелльшафт (De) Композиция для мужской контрацепции, включающая норэтистерон
MXPA03001147A (es) * 2000-08-23 2003-10-06 Akzo Nobel Nv Nueva formulacion de ester de testosterona para uso humano.

Similar Documents

Publication Publication Date Title
AU2021203809B2 (en) Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
EP1743646A3 (en) Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
ES2253423T3 (es) Formulacion de un ester de testosterona para uso humano.
JP2003519659A5 (enExample)
WO2008093772A1 (ja) 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
BR0107445A (pt) Formulação farmacêutica, uso de fulvestrante na preparação de uma formulação farmacêutica, e, seringa ou frasco
RU2009120528A (ru) Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла
AU2001291775A1 (en) Testosterone ester formulation for human use
JP2003512474A5 (enExample)
EA200100108A1 (ru) Применение биогенных сульфаматов эстрогенов для гормонзаместительной терапии
WO2020188448A1 (en) Toll-like receptor agonists for use in the treatment of hepatitis b
RU2004138811A (ru) Контрацептивная инъекция масляного раствора, вводимая самостоятельно
BR112012015016B8 (pt) formulação farmacêutica, forma de dosagem farmacêutica entérica e uso de uma formulação
KR960014152A (ko) 17-스피로메틸렌 락톤 또는 락톨 그룹을 갖는 스테로이드
Waizmann et al. High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD)(PEGASYS) and once-daily ribavirin
Garza-Flores Pharmacokinetics of once-a-month injectable contraceptives
RU2002124602A (ru) Композиция для мужской контрацепции, включающая норэтистерон
AP1707A (en) Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same.
TH82739A (th) การคุมกำเนิดที่ใช้ได้ด้วยตัวเอง
CN2582628Y (zh) 防回拉一次性注射器
CN1597005A (zh) 自废式一次性无菌注射器
CN200966822Y (zh) 安全注射装置
CN202777309U (zh) 用于肌肉注射的注射器
CN2680276Y (zh) 防回拉一次性注射器
Hui Amikacin/cefoxitin/clarithromycin/linezolid